Zobair Younossi - Dissemin

All papers authored by Zobair Younossi

This paper is made freely available by the publisher.

2021 Zobair M. Younossi

, Maria Stepanova, Mazen Noureddin, Kris V. Kowdley

, Simone I. Strasser, Anita Kohli, Peter Ruane, Mitchell L. Shiffman, Aasim Sheikh, Nadege Gunn, Stephen H. Caldwell, Ryan S. Huss, Robert P. Myers, Vincent Wai‐Sun Wong

, Naim Alkhouri and 2 other authors

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2019 Zobair M. Younossi

, Maria Stepanova, Issah Younossi, George Papatheodoridis

, Harry L. A. Janssen, Kosh Agarwal

, Mindie H. Nguyen

, Ed Gane, Naoky Tsai, Fatema Nader

Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication

Upload

Donghee Kim

, George Cholankeril, Andrew A. Li

, Won Kim

, Sean P. Tighe, Bilal Hameed, Paul Y. Kwo, Stephen A. Harrison, Zobair M. Younossi

, Aijaz Ahmed

Trends in Hospitalizations for Chronic Liver Disease‐related Liver Failure in the United States, 2005‐2014

Upload

Uchenna Agbim, Yu Jiang, Satish K. Kedia, Ashwani K. Singal

, Aijaz Ahmed

, Kalyan Ram Bhamidimarri, David E. Bernstein, Stephen A. Harrison, Zobair M. Younossi

, Sanjaya K. Satapathy

Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

Upload

2018 Donghee Kim

, Won Kim

, Sae Kyung Joo, Jung Ho Kim, Stephen A. Harrison, Zobair M. Younossi

, Aijaz Ahmed

Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease

Upload

Andrew A. Li, Donghee Kim

, Won Kim

, Pratima Dibba, Katherine Wong, George Cholankeril, Ira M. Jacobson, Zobair M. Younossi

, Aijaz Ahmed

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

Upload

Linda L. Henry, Zobair M. Younossi

Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives

Upload

Zobair M. Younossi

, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, William R. Lenderking, Anne Skalicky

, Leah Kleinman, Robert P. Myers, G. Mani Subramanian, John G. McHutchison, Cynthia Levy, Christopher L. Bowlus

and 2 other authors

Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO

Upload

S. L. Flamm, B. Bacon, M. P. Curry

, S. Milligan, C. U. Nwankwo, N. Tsai, Z. Younossi

, N. Afdhal

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network

Upload

Zobair M. Younossi

The epidemiology of nonalcoholic steatohepatitis: Epidemiology of NASH

Download from aasldpubs.onlinelibrary.wiley.com

P. Cacoub, P. Buggisch, J. A. Carrión, G. S. Cooke, A. L. Zignego, R. Beckerman

, Z. Younossi

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

Upload

Zobair M. Younossi

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation: Younossi

Upload

Zobair M. Younossi

The efficacy of new antiviral regimens for hepatitis C infection: Evidence from a systematic review: Hepatology Elsewhere

Upload

Zobair M. Younossi

, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Nguyen Kinh, Ching Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei Lai

The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C

Upload

2017 Z. M. Younossi

, M. Stepanova, K. B. Schwarz, S. Wirth, P. Rosenthal, R. Gonzalez-Peralta, K. Murray, L. Henry, S. Hunt

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin

Upload

This paper is available in a repository.

P. Cacoub, M. Vautier, A. C. Desbois

, D. Saadoun, Z. Younossi

Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France

Download from hal.sorbonne-universite.fr

Zobair Younossi

, Deidre Blissett, Rob Blissett, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

Upload

M. P. Curry

, E. B. Tapper, B. Bacon, D. Dieterich, S. L. Flamm, L. Guest, K. V. Kowdley, Y. Lee, S. Milligan, N. Tsai, Z. Younossi

, N. H. Afdhal

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients

Upload

Zobair M. Younossi

, Maria Stepanova, Nila Rafiq, Linda Henry, Rohit Loomba, Hala Makhlouf, Zachary Goodman

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease: Hepatology Communications, Vol. XX, No. X, 2017

Download from doi.org

K. Young, B. Liu, T. Bhuket, Z. Younossi

, S. Saab

, A. Ahmed, R. J. Wong

Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Zobair Younossi